Bilaketaren emaitzak - Angela Panoskaltsis‐Mortari
- Erakusten 1 - 20 emaitzak -- 100
- Go to Next Page
-
1
3D bioprinting for lungs and hollow organs nork Zachary Galliger, Caleb Vogt, Angela Panoskaltsis‐Mortari
Argitaratua 2019Revisão -
2
Leukocyte migration and graft-versus-host disease nork Christian Wysocki, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Argitaratua 2005Revisão -
3
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility co... nork BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, GS Gray, DA Vallera
Argitaratua 1995Artigo -
4
-
5
-
6
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines nork Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Daniel A. Vallera
Argitaratua 1998Artigo -
7
-
8
-
9
-
10
-
11
-
12
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations nork Michael Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Argitaratua 2008Artigo -
13
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients nork Bruce R. Blazar, Byoung S. Kwon, Angela Panoskaltsis‐Mortari, Kyu B. Kwak, Jacques J. Peschon, Patricia A. Taylor
Argitaratua 2001Artigo -
14
-
15
-
16
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality nork Lisa K. Jasperson, Christoph Bucher, Angela Panoskaltsis‐Mortari, Andrew L. Mellor, David H. Munn, Bruce R. Blazar
Argitaratua 2009Artigo -
17
CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or... nork Bruce R. Blazar, Patricia A. Taylor, Michael W. Boyer, Angela Panoskaltsis‐Mortari, James P. Allison, Daniel A. Vallera
Argitaratua 1997Artigo -
18
-
19
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. nork Bruce R. Blazar, Arlene H. Sharpe, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, G S Gray, Robert Korngold, Daniel A. Vallera
Argitaratua 1996Artigo -
20
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients nork Patricia A. Taylor, Michael Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Bruce R. Blazar
Argitaratua 2006Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Immunology
Biology
Medicine
Internal medicine
Immune system
Graft-versus-host disease
Cancer research
Biochemistry
T cell
Cell biology
Transplantation
In vitro
Stem cell
Genetics
Cytotoxic T cell
Pathology
Receptor
Disease
CD8
Bone marrow
Lung
Antibody
Antigen
Chemistry
Leukemia
Cytokine
Gene
Chemotherapy
Inflammation
Adoptive cell transfer